@article{746662b1fd6b426d83938c0a45abbc87,
title = "Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom",
author = "Roos, {Jonathan C. P.} and Rachna Murthy",
note = "Funding Information: Conflict of interest Susan Downes Disclosure: PI on relevant commercially sponsored trials in last 5 years: Novartis, Bayer, and Alcon. Prof Susan Downes has received honoraria in the past 15 years from Novartis and Bayer for speaking at educational meetings, as well as travel expenses from Ely Lilly as chair for diabetic retinopathy screening meetings, and Novartis to attend educational meetings in Medical Retina pre 2010. She is a PI on a number of commercial trials (Novartis, Roche, Bayer, Allergen, among others), and has received a bursary for a research nurse practitioner, and equipment (visudyne pump for photodynamic therapy) and funding to carry out genetic testing for a research project from Novartis. She also has has been a co-PI or Pl on grants from Wellcome, UK Fighting Blindness RP, Fight for Sight and UK NIHR/CRN funding. The remaining authors declare that they have no conflict of interest. Funding Information: Funding This work was funded by the Fortisure Foundation, That Man May See, and Research to Prevent Blindness. Funding Information: Acknowledgements This work was supported by the National Institute for Health Research (NIHR) Moorfields Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2019",
month = feb,
day = "1",
doi = "10.1038/s41433-018-0303-0",
language = "English",
volume = "33",
pages = "327--342",
journal = "Eye (Basingstoke)",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "2",
}